Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niccola Funel

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
World Journal of Gastroenterology|December 8, 2021
Detailing the ultrastructure's increase of prion protein in pancreatic adenocarcinomaMatteo Bianchini, Maria Anita Giambelluca, Maria Concetta Scavuzzo, et al.
Nature Communications|May 12, 2018
TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progressionSilvia Ottaviani, Justin Stebbing, Adam E Frampton, et al.
Ebiomedicine|December 25, 2018
Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesotheliomaRocco Sciarrillo, Anna Wojtuszkiewicz, Btissame El Hassouni, et al.
Gastroenterology|October 15, 2013
MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progressionAdam E Frampton, Leandro Castellano, Teresa Colombo, et al.
Experimental Hematology & Oncology|December 1, 2023
A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary diseaseMireia Mato Prado, Jisce R Puik, Leandro Castellano, et al.
Carcinogenesis|August 7, 2016
Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patientsCosmeri Rizzato, Daniele Campa, Renata Talar-Wojnarowska, et al.
British Journal of Cancer|June 5, 2020
Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compoundsGiovanna Li Petri, Btissame El Hassouni, Rocco Sciarrillo, et al.
Carcinogenesis|June 6, 2018
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasmsOfure Obazee, Gabriele Capurso, Francesca Tavano, et al.
Carcinogenesis|January 9, 2018
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasmsOfure Obazee, Gabriele Capurso, Francesca Tavano, et al.
Scientific Reports|December 24, 2016
Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumorsDaniele Campa, Gabriele Capurso, Manuela Pastore, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
World Journal of Gastroenterology|December 8, 2021
Detailing the ultrastructure's increase of prion protein in pancreatic adenocarcinomaMatteo Bianchini, Maria Anita Giambelluca, Maria Concetta Scavuzzo, et al.
Nature Communications|May 12, 2018
TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progressionSilvia Ottaviani, Justin Stebbing, Adam E Frampton, et al.
Ebiomedicine|December 25, 2018
Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesotheliomaRocco Sciarrillo, Anna Wojtuszkiewicz, Btissame El Hassouni, et al.
Gastroenterology|October 15, 2013
MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progressionAdam E Frampton, Leandro Castellano, Teresa Colombo, et al.
Experimental Hematology & Oncology|December 1, 2023
A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary diseaseMireia Mato Prado, Jisce R Puik, Leandro Castellano, et al.
Carcinogenesis|August 7, 2016
Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patientsCosmeri Rizzato, Daniele Campa, Renata Talar-Wojnarowska, et al.
British Journal of Cancer|June 5, 2020
Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compoundsGiovanna Li Petri, Btissame El Hassouni, Rocco Sciarrillo, et al.
Carcinogenesis|June 6, 2018
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasmsOfure Obazee, Gabriele Capurso, Francesca Tavano, et al.
Carcinogenesis|January 9, 2018
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasmsOfure Obazee, Gabriele Capurso, Francesca Tavano, et al.
Scientific Reports|December 24, 2016
Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumorsDaniele Campa, Gabriele Capurso, Manuela Pastore, et al.
Pageof 10